Immatics Newsroom

Goldman Sachs Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $13.5

Futu NewsNov 26 06:31

Immatics Analyst Ratings

BenzingaNov 20 01:31

BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 19 22:31

Jefferies Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 19 21:31

Leerink Partners Maintains Immatics(IMTX.US) With Buy Rating, Announces Target Price $18

Futu NewsNov 19 16:39

BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Cuts Target Price to $15

Futu NewsNov 19 16:36

Immatics' Promising Immunotherapy Developments Bolster Jonathan Chang's Buy Rating

TipRanksNov 12 15:48

Piper Sandler Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $19

Futu NewsNov 6 20:31

Analysts Conflicted on These Healthcare Names: AnaptysBio (ANAB), Stoke Therapeutics (STOK) and Immatics (IMTX)

TipRanksNov 6 20:17

Buy Rating Affirmed for Immatics Amidst Promising Clinical Trials and Strategic Positioning in TCR Therapeutics

TipRanksOct 15 14:47

Immatics Initiated at Overweight by Piper Sandler

Dow JonesOct 7 20:00

Immatics Analyst Ratings

BenzingaOct 7 19:50

Piper Sandler Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $19

Futu NewsOct 7 17:33

Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $16

Futu NewsSep 14 00:32

Leerink Partners Remains a Buy on Immatics (IMTX)

TipRanksSep 11 14:10

Immatics Analyst Ratings

BenzingaSep 5 23:22

Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $16

Futu NewsAug 16 18:31

Buy Rating for Immatics: Promising Clinical Trials and Strong Financials Signal Upside Potential

TipRanksAug 16 18:06

BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $16

Futu NewsAug 14 17:34

Buy Rating Affirmed on Immatics' Promising Pipeline and Upcoming Data Catalysts

TipRanksAug 14 16:43